Furthermore, igfr1 deletion in CD4+ T cells reduced IL-17A-expressing CD4+ T cell levels, increased central nervous systems-infiltrating Tregs, and protected against experimental autoimmune encephalomyelitis (34). Here, CD4 is linked to experimental autoimmune encephalomyelitis.